461 Updated PFS analysis of toripalimab with anlotinib and chemotherapy as first-line therapy in patients with extensive-stage small-cell lung cancer (ES-SCLC)

Hao Luo; Dan Jian; Yan Feng; Li Zhong; Qian Chen; Wei Guan; Shiheng Zhang; Jiamin Luo; Xueqin Yang; Kan Gong; Yanli Xiong; Mengxia Li; Mingfang Xu; Yu Pu; Liang Zhao; Chengyuan Qian; Nan Dai; Dong Wang

doi:10.1136/jitc-2021-SITC2021.461

Article info

Regular and Young Investigator Award Abstracts

Clinical Trials In Progress

461 Updated PFS analysis of toripalimab with anlotinib and chemotherapy as first-line therapy in patients with extensive-stage small-cell lung cancer (ES-SCLC)

Free

Authors

Hao Luo Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Dan Jian Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Yan Feng Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Li Zhong Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Qian Chen Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Wei Guan Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Shiheng Zhang Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Jiamin Luo Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Xueqin Yang Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Kan Gong Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Yanli Xiong Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Mengxia Li Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Mingfang Xu Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Yu Pu Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Liang Zhao Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Chengyuan Qian Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Nan Dai Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles
Dong Wang Cancer Center of Daping Hospital, Army Medical Center, Chongqing, China PubMed articles Google scholar articles

Citation

Luo H, Jian D, Feng Y, et al

461 Updated PFS analysis of toripalimab with anlotinib and chemotherapy as first-line therapy in patients with extensive-stage small-cell lung cancer (ES-SCLC)

Journal for ImmunoTherapy of Cancer 2021;9:doi: 10.1136/jitc-2021-SITC2021.461

Publication history

First published November 10, 2021.

Online issue publication

March 30, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Main menu

Authors

Citation

Publication history

Request permissions

Copyright information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Authors

Citation

Publication history

Request permissions

Copyright information

Read the full text or download the PDF:

Log in using your username and password